S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

BPMC Blueprint Medicines Corporation

96.38

1.28 (1.35%)

30 Nov 2024 - Closed

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Blueprint Medicines Charts.

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Blueprint Medicines Charts.

Blueprint Medicines Corporation News

Form 144 - Report of proposed sale of securities
Saturday 30 November 2024 (2 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 28 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 23 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 22 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 21 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Wednesday 13 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 31 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 30 October 2024 (1 month ago) • Edgar (US Regulatory)

Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
Wednesday 30 October 2024 (1 month ago) • PR Newswire (US)

Blueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
Wednesday 16 October 2024 (2 months ago) • PR Newswire (US)

More Blueprint Medicines Corporation News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions